Review Article

The Histone Modification Code in the Pathogenesis of Autoimmune Diseases

Table 1

Histone methylation and histone methylation-modifying enzymes.

Histone and
resides
States of methylationHMTsHDMs

Lysineme1me2me3

H2BK5AUnknownUnknown
H3K4AAAMLL1, MLL2, MLL3, MLL4, ML5, SET1A, SET1B, ASH1L, SET7/9, SMYD3, PRDM9LSD1, AOF1, FBXL10, JARID1A, JARID1B, JARID1C, JARID1D, JARID2, NO66
H3K9ARRSUV39H1, SUV39H2, G9A, GLP, SETDB1, SETDB2, PRDM1, PRDM2, PRDM4LSD1, JMJD1A, JMJD1B, JMJD1C, JMJD2A, JMJD2B, JMJD2C, JMJD2D, PHF8, JHDM1D
H3K27ARREZH1, EZH2UTX, UTY, JMJD3, JHDM1D
H3K36ASETD2, NSD1, NSD2, NSD3, SMYD1, SMYD2, SMYD3, SMYD4, SMYD5FBXL10, FBXL11, JMJD2A, JMJD2B, JMJD2C, NO66
H3K79A or RDOT1PHF8
H4K20ARPR-Set7, SUV4-20H1, SUV4-20H/2, SET7/9Unknown

Arginineme1me2ame2s

H3R2AA or Rme2a: PRMT6Unknown
H3R8Rme2s: PRMT5Unknown
H3R17Ame2a: CARM1Unknown
H3R26Ame2a: CARM1Unknown
H4R3ARme2a: PRMT1, PRMT6, PRMT8
me2s: PRMT5, PRMT7
Unknown

—: function is unknown, A: an active marker, and R: a repressive marker.
me1: monomethylation, me2: dimethylation, me3: trimethylation, me2s: symmetrical dimethylation, and me2a: asymmetrical demethylation.